Armata Pharmaceuticals (ARMP) Cash from Investing Activities Growth (1y) (2014 - 2026)
Armata Pharmaceuticals (ARMP) Cash from Investing Activities Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Armata Pharmaceuticals | 187.95 Mn | 183.15 Mn | - | 36.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.36% |
| Dec 31, 2025 | -167.53% |
| Sep 30, 2025 | 28.82% |
| Jun 30, 2025 | 89.09% |
| Mar 31, 2025 | 60.40% |
| Dec 31, 2024 | 103.22% |
| Sep 30, 2024 | 90.32% |
| Jun 30, 2024 | -515.32% |
| Mar 31, 2024 | 87.56% |
| Dec 31, 2023 | -625.27% |
| Sep 30, 2023 | -171.41% |
| Jun 30, 2023 | 80.46% |
| Mar 31, 2023 | -751.69% |
| Dec 31, 2022 | 299.56% |
| Sep 30, 2022 | -122.34% |
| Jun 30, 2022 | -479.59% |
| Mar 31, 2022 | 20.81% |
| Dec 31, 2021 | 37.70% |
| Sep 30, 2021 | -618.52% |
| Jun 30, 2021 | 28.21% |